Dr Mariola Söhngen, CEO, Mologen 00:00:00
Mologen is a German biotech company developing cancer immunotherapies. Their lead product is Lefitolimod (MGN1703) which is being tested in a phase III trial for metastatic colorectal cancer
Mologen is a German biotech company developing cancer immunotherapies. Their lead product is Lefitolimod (MGN1703) which is being tested in a phase III trial for metastatic colorectal cancer